| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
147,734 |
129,903 |
$10.24M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
18,632 |
17,138 |
$4.51M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,426 |
14,423 |
$2.71M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
8,447 |
4,446 |
$1.82M |
| 36415 |
Collection of venous blood by venipuncture |
58,452 |
49,403 |
$1.36M |
| 90870 |
|
3,035 |
1,167 |
$711K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
34,026 |
28,826 |
$529K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,663 |
2,333 |
$489K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
19,230 |
16,977 |
$441K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,571 |
4,320 |
$358K |
| 80053 |
Comprehensive metabolic panel |
13,978 |
11,493 |
$323K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,469 |
3,225 |
$264K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,949 |
2,440 |
$213K |
| 90834 |
Psychotherapy, 45 minutes with patient |
4,096 |
2,701 |
$181K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
2,337 |
2,150 |
$120K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
254 |
229 |
$95K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,013 |
4,172 |
$79K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,158 |
5,494 |
$71K |
| 81001 |
|
3,747 |
3,240 |
$70K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,445 |
318 |
$68K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
979 |
571 |
$67K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,725 |
1,604 |
$66K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
687 |
614 |
$57K |
| 90837 |
Psychotherapy, 53 minutes with patient |
575 |
413 |
$53K |
| 99233 |
Prolong inpt eval add15 m |
748 |
203 |
$51K |
| 97161 |
|
1,341 |
1,211 |
$50K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,789 |
1,530 |
$49K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,601 |
1,328 |
$49K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
890 |
421 |
$47K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,865 |
928 |
$46K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,774 |
1,517 |
$45K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,228 |
1,018 |
$44K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,083 |
1,590 |
$44K |
| 92015 |
Determination of refractive state |
2,175 |
2,005 |
$43K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
72 |
64 |
$43K |
| 80076 |
|
2,967 |
2,591 |
$40K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,417 |
2,316 |
$40K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,017 |
1,808 |
$36K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
346 |
312 |
$36K |
| 11045 |
|
123 |
65 |
$35K |
| 97597 |
|
537 |
347 |
$35K |
| 91300 |
|
2,255 |
1,989 |
$34K |
| 29581 |
|
137 |
74 |
$33K |
| 99223 |
Prolong inpt eval add15 m |
249 |
208 |
$32K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
560 |
546 |
$30K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,809 |
3,494 |
$30K |
| 70450 |
Computed tomography, head or brain; without contrast material |
214 |
184 |
$30K |
| 80061 |
Lipid panel |
3,100 |
2,814 |
$29K |
| 71045 |
Radiologic examination, chest; single view |
674 |
613 |
$29K |
| J2704 |
Injection, propofol, 10 mg |
2,616 |
2,268 |
$26K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
358 |
255 |
$25K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
212 |
207 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
1,083 |
953 |
$22K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
680 |
663 |
$21K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,790 |
1,133 |
$20K |
| 83735 |
|
2,950 |
2,108 |
$18K |
| 0002A |
|
1,254 |
1,208 |
$18K |
| 0001A |
|
1,296 |
1,251 |
$18K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,368 |
1,001 |
$18K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,899 |
2,475 |
$17K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
908 |
780 |
$17K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
238 |
226 |
$16K |
| 82565 |
|
593 |
502 |
$16K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
3,184 |
2,718 |
$16K |
| 80306 |
|
1,448 |
1,114 |
$16K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,306 |
2,667 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
482 |
345 |
$15K |
| 83690 |
|
1,579 |
1,345 |
$14K |
| 85027 |
|
1,769 |
1,579 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,229 |
1,171 |
$13K |
| 86140 |
|
2,818 |
2,433 |
$13K |
| 81003 |
|
1,255 |
1,063 |
$12K |
| J3490 |
Unclassified drugs |
1,338 |
480 |
$12K |
| 99222 |
Initial hospital care, per day, moderate complexity |
142 |
124 |
$11K |
| 86780 |
|
1,257 |
1,082 |
$11K |
| 82948 |
|
984 |
459 |
$11K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
18 |
12 |
$10K |
| 85610 |
|
2,079 |
1,387 |
$10K |
| 84484 |
|
745 |
474 |
$10K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
398 |
140 |
$10K |
| 69210 |
|
306 |
296 |
$9K |
| 0003A |
|
558 |
548 |
$9K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
557 |
493 |
$9K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
204 |
187 |
$9K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
42 |
38 |
$8K |
| 86481 |
|
86 |
80 |
$8K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
153 |
147 |
$7K |
| 64615 |
|
57 |
52 |
$7K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,968 |
1,488 |
$7K |
| 93296 |
|
214 |
205 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
61 |
59 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,644 |
1,240 |
$6K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
84 |
82 |
$6K |
| 83615 |
|
651 |
467 |
$5K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
257 |
231 |
$5K |
| 91307 |
|
307 |
285 |
$5K |
| 20553 |
|
41 |
38 |
$5K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
158 |
147 |
$5K |
| 86850 |
|
1,344 |
1,050 |
$4K |
| 87340 |
|
510 |
427 |
$4K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
122 |
53 |
$4K |
| 82607 |
|
387 |
340 |
$4K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
76 |
69 |
$4K |
| 0013A |
|
222 |
220 |
$4K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
41 |
40 |
$4K |
| 87077 |
|
716 |
630 |
$4K |
| 87081 |
|
352 |
317 |
$4K |
| 84439 |
|
631 |
512 |
$4K |
| 90662 |
|
253 |
242 |
$4K |
| 87070 |
|
820 |
765 |
$4K |
| 86803 |
|
325 |
270 |
$4K |
| 87522 |
Neg quan hep c or qual rna |
72 |
70 |
$4K |
| 82728 |
|
446 |
396 |
$3K |
| 87653 |
|
98 |
92 |
$3K |
| 92551 |
|
52 |
50 |
$3K |
| G0378 |
Hospital observation service, per hour |
240 |
95 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
318 |
147 |
$3K |
| 0054A |
|
162 |
159 |
$3K |
| 87186 |
|
543 |
483 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
229 |
219 |
$3K |
| 90688 |
|
228 |
227 |
$3K |
| 84145 |
|
98 |
90 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
56 |
55 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,424 |
1,579 |
$3K |
| 83550 |
|
620 |
558 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18 |
17 |
$3K |
| 0124A |
|
105 |
103 |
$3K |
| 80069 |
|
151 |
127 |
$3K |
| 83655 |
|
248 |
229 |
$3K |
| 0072A |
|
139 |
139 |
$3K |
| 83540 |
|
760 |
680 |
$3K |
| 0071A |
|
137 |
136 |
$2K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
27 |
25 |
$2K |
| 91306 |
|
179 |
177 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
15 |
13 |
$2K |
| 95886 |
|
13 |
12 |
$2K |
| 92557 |
|
37 |
36 |
$2K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
50 |
40 |
$2K |
| 91305 |
|
151 |
149 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
865 |
680 |
$2K |
| G0008 |
Administration of influenza virus vaccine |
548 |
519 |
$2K |
| 84100 |
|
210 |
154 |
$2K |
| 86762 |
|
119 |
108 |
$2K |
| 86900 |
|
758 |
580 |
$2K |
| 90686 |
|
671 |
654 |
$2K |
| 86901 |
|
816 |
613 |
$1K |
| 92567 |
|
193 |
186 |
$1K |
| 85652 |
|
613 |
537 |
$1K |
| 97535 |
Self-care/home management training, each 15 minutes |
74 |
44 |
$1K |
| 84550 |
|
152 |
120 |
$1K |
| 81025 |
|
93 |
76 |
$1K |
| 97162 |
|
40 |
36 |
$1K |
| 73630 |
|
71 |
61 |
$985.37 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,894 |
1,385 |
$872.32 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,390 |
1,073 |
$824.96 |
| 0031A |
|
76 |
49 |
$813.06 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
13 |
12 |
$764.62 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
20 |
18 |
$752.13 |
| 83605 |
|
136 |
100 |
$735.85 |
| 91301 |
|
47 |
46 |
$688.16 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
32 |
15 |
$681.42 |
| 82077 |
|
14 |
13 |
$654.86 |
| 91322 |
|
12 |
12 |
$620.97 |
| 84460 |
|
159 |
146 |
$619.62 |
| 82043 |
|
244 |
206 |
$574.04 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
12 |
12 |
$561.06 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
117 |
92 |
$523.99 |
| 91303 |
|
74 |
48 |
$516.12 |
| 86618 |
|
32 |
28 |
$456.19 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
26 |
26 |
$445.80 |
| 90682 |
|
27 |
25 |
$429.91 |
| 90480 |
|
24 |
24 |
$403.13 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$358.70 |
| 84481 |
|
31 |
27 |
$349.68 |
| 0012A |
|
41 |
40 |
$314.80 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
14 |
13 |
$305.43 |
| A9270 |
Non-covered item or service |
5,949 |
1,029 |
$281.98 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
607 |
456 |
$278.62 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
27 |
27 |
$275.13 |
| 85018 |
|
204 |
176 |
$264.30 |
| 0011A |
|
20 |
20 |
$257.44 |
| 91311 |
|
30 |
28 |
$254.76 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
12 |
12 |
$205.24 |
| 0052A |
|
12 |
12 |
$201.84 |
| 84450 |
|
24 |
24 |
$191.90 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
12 |
12 |
$147.50 |
| 99173 |
|
37 |
35 |
$145.53 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
53 |
29 |
$133.68 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
196 |
146 |
$118.41 |
| 0074A |
|
12 |
12 |
$112.32 |
| 94726 |
|
14 |
14 |
$104.19 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
23 |
20 |
$98.67 |
| 92134 |
|
497 |
391 |
$92.03 |
| 99490 |
Ccm add 20min |
64 |
61 |
$72.67 |
| 0111A |
|
14 |
13 |
$66.96 |
| 94729 |
|
13 |
13 |
$64.38 |
| 87205 |
|
14 |
12 |
$41.24 |
| 84156 |
|
15 |
12 |
$40.73 |
| 36416 |
|
32 |
26 |
$19.72 |
| 88342 |
|
17 |
13 |
$11.78 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
15 |
14 |
$4.04 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
21 |
12 |
$0.00 |
| 90656 |
|
15 |
15 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
61 |
25 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
108 |
66 |
$0.00 |
| 67028 |
Intravitreal injection of a pharmacologic agent |
50 |
37 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
76 |
41 |
$0.00 |
| 90670 |
|
25 |
25 |
$0.00 |